Garofoli

Mark Garofoli, PharmD, MBA, BCGP, CPE

Director of Experiential Learning

Contact

Send an Email
Phone
304-293-6341
Fax
304-293-7672
Room
1120B, HSC North, Floor 1
Address
PO Box 9520
64 Medical Center Drive
Morgantown, WV 26505
Download Curriculum Vitae
Additions & Corrections?

Positions

Director of Experiential Learning
Clinical Associate Professor
Faculty, WVU School of Medicine Pain Fellowship Program
Clinical Pain/Addiction Pharmacist, WVU Medicine Pain Clinic

Organization:
School of Pharmacy
Department:
Clinical Pharmacy
Classification:
Admin

Education

  • PharmD, University of Pittsburgh School of Pharmacy, 2004
  • MBA, Strayer University (Management Concentration), 2008

Publications

Garofoli MP. “Drug Diversion Prevention”. 20 Ways. Summer Hospital Edition 2025. Garofoli MP, “How to Prescribe Opioids Using Best Practices”. Med Central; March 2025.

Garofoli MP, “Naloxone: Pharmacology, Myths, and Societal Concerns”. Med Central; August 12th , 2024. Garofoli MP. “One Way to Save Lives”. 20 Ways. Summer Hospital Edition 2024.
 
Adler J, Mallick-Searle T, Garofoli M, Zimmerman A. Frontline Perspectives on Buprenorphine for the Management of Chronic Pain. J Multidiscip Healthc. 2024 Mar 27; 17: 1375-1383.
 
Garofoli MP. “A Joint Effort: Cannabis Update for Pharmacists”. Pharmacy Today Continuing Education (PTCE). 2023; 29 (10).
 
Garofoli MP, “Polypharmacy in Pain Management: A Clinical Primer to Drug Interactions?”. Practical Pain Management. 2023; 23(5).
 
Garofoli MP, Hanif A, Sraj S, Kuhn S. “Perceptions of West Virginia Teens and Adults Regarding the Risks of Over-the-Counter Pain Medications”. Journal of Pain and Palliative Care Pharmacotherapy. 2023; 23(1). Garofoli MP, “Prescribing and Dispensing Controlled Substances: When to Pump the Brakes”. Practical Pain Management. 2022; 22(6).
 
Garofoli MP, “Perspective: Geriatric Pain Management – What’s Left to Prescribe?”. Practical Pain Management. 2022; 22(1).
 
Hale M, Garofoli MP, Raffa R. Benefit-Risk Analysis of Buprenorphine for Pain Management. Journal of Pain Research. 24 May 2021 Volume 2021: 14 Pages 1359-1369.
 
Garofoli MP, “Abuse Deterrent Formulation Types and Goals”. PAINWeek One Minute Clinician. July 1st , 2020.
 
Klinker DM, Brownfield A, Thomas A, Garofoli MP, Beckers C, Jefferson CG, Joseph AS, Peppard S, Stultz K. An AACP Experiential Education Report: National Survey of Staffing, Responsibilities, and Challenges within Pharmacy Experiential Education (EE) Programs. AACP Report. July 2020.
 
Garofoli MP, “Editorial: From Just Say No, to Say Now and Say Know: Substances of abuse need to be part of clinical training and continuing education”. Practical Pain Management. 2020; 20(2):9-10.
 
Winstanley EL, Baugh GM, Garofoli MP, and Muzyk AJ, “Experiences and opinions of health professional students participating in an opioid use disorder educational event. Mental Health Clinician. 2020; 10(2): 49-54. Garofoli MP. Adolescent Substance Abuse. Prim Care Clin Office Pract 47 (2020) 383–394.
 
Hines KL, Garofoli GM, Garofoli MP, Elswick BM, and Winstanley EL, “Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy”. Journal of the American Pharmacists Association. (60) 2020: e205-e214.
 
Garofoli MP, “Spuds, Screenings, & Safety: From Chips to Opioids”. PAINWeek Journal. 2019; 7(2):10. Garofoli MP. “CDC Guideline Op-Ed”. PAINWeek Journal. 2019; 7(2):5.
 
Garofoli MP. “PAINWeek Next Generation”. PAINWeek Journal. 2019; 7(1):3.
 
Garofoli MP. Ask the Expert: What Types of Risk Screening Tests are Available for Clinicians Prescribing Opioid Therapy? Practical Pain Management. 2018; 18(8):10-12.
 
Garofoli MP, et al. The West Virginia Safe & Effective Management of Pain (SEMP) Guidelines. Sept 2016.
 
Garofoli MP, “Tylenol Overdose.” On Being a Pharmacist: True Stories by Pharmacists. Ed. Pangilinan J, et al. Washington, D.C.: American Pharmacists Association, 2010. 107-108.

Additional Info

Practice, Research, and Scholarship Interests

Experiential Learning

Pain Management

Medication Therapy Management (MTM)

Geriatric Care

Medical Marijuana

Substance Abuse

Drug Diversion

Substance-Use Disorder (Addiction)

 

 

About Mark Garofoli

Mark is a University of Pittsburgh PharmD graduate, Strayer MBA graduate, Board-Certified Geriatric Pharmacist (BCGP), Certified Pain Educator (CPE), and Certified Tobacco Treatment Specialist (CTTS). His past positions include being a pharmacist leader with CVS Health, Humana, and the WV Safe & Effective Management of Pain (SEMP) Program, along with coordinating the WV SEMP Guidelines Panel. Today, he is WVU School of Pharmacy faculty, WVU School of Pharmacy Director of Experiential Learning, WVU School of Medicine Pain Fellowship Faculty, and a WVU Medicine Pain & Addiction Pharmacist. Mark “Pain Guy” Garofoli has been a 2021 TEDx Talker, CDC grant reviewer, civil/criminal expert witness, seasoned CE developer and presenter, host of the Pain Pod (Pharmacy Podcast Network), Editor of the Pain Press, and publishes the www.painguy.us website.

Additional Info

Professional Memberships

International Association for the Study of Pain (IASP) 

WVU School of Pharmacy Alumni Association (Honorary Member) 

American Society of Pain Educators (ASPE) 

West Virginia Pharmacist’s Association (WVPA) 

American Association of Colleges of Pharmacy (AACP) 

APhA Pain, Palliative Care, & Addiction SIG 

American Society of Consultant Pharmacists (ASCP) 

University of Pittsburgh Alumni Association 

Phi Lambda Sigma Pharmacy Leadership Society (PLS) 

Kappa Psi Pharmaceutical Fraternity Inc. (KΨ)